← Back to Search

Behavioural Intervention

Nerve Stimulation + Knee Brace for Post-Stroke Mobility Improvement

N/A
Recruiting
Led By James S Sulzer
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged at least 18
Able to continuously walk for 30 minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights

Study Summary

This trial is testing if electrical stimulations to the rectus femoris (a thigh muscle) can help with movement for people who have post-stroke stiff-knee gait.

Who is the study for?
This trial is for adults who were independent before and can walk continuously for 30 minutes. It's specifically aimed at those with post-stroke stiff-knee gait, which means they have trouble bending their knee when walking due to a stroke. Participants should have mild to moderate impairment and be able to give consent.Check my eligibility
What is being tested?
The study tests how electrical stimulation of the nerve that controls the thigh muscle affects reflexes in people with stiff knees after a stroke compared to those without this condition. Additionally, it examines if these reflexes are linked to changes in walking patterns.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort or skin irritation from the electrical stimulation or brace wear, muscle fatigue from prolonged walking tests, and possible temporary increase in spasticity or stiffness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can walk non-stop for 30 minutes.
Select...
I have weakness on one side of my body after a stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surface electromyographic recording of leg muscles during different conditions
Secondary outcome measures
Circumduction measure

Trial Design

2Treatment groups
Experimental Treatment
Group I: Post-stroke Stiff-Knee Gait ParticipantsExperimental Treatment1 Intervention
Individuals with post-stroke Stiff-Knee gait
Group II: Healthy IndividualsExperimental Treatment2 Interventions
Healthy Individuals

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,184 Total Patients Enrolled
MetroHealth Medical CenterLead Sponsor
114 Previous Clinical Trials
21,329 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,737 Total Patients Enrolled

Media Library

Peripheral nerve stimulation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04947865 — N/A
Sensorimotor Gait Disorder Research Study Groups: Post-stroke Stiff-Knee Gait Participants, Healthy Individuals
Sensorimotor Gait Disorder Clinical Trial 2023: Peripheral nerve stimulation Highlights & Side Effects. Trial Name: NCT04947865 — N/A
Peripheral nerve stimulation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04947865 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have elected to participate in this experimentation?

"Affirmative. Details on clinicaltrials.gov indicate that this trial, which was initially posted on June 11th 2021, is actively seeking participants and has recently been updated (June 23rd 2021). The study requires 60 individuals at one medical site."

Answered by AI

Are individuals currently being enrolled for this scientific research study?

"Affirmative. The clinical trial's details available on the online platform, clinicaltrials.gov, confirm that this research is actively recruiting patients as of June 23rd 2021--the date of its most recent update. 60 test subjects are necessary for one medical centre to partake in this study, which began recruitment efforts on November 6th 2021."

Answered by AI
~16 spots leftby Jun 2025